Pages that link to "Item:Q3078933"
From MaRDI portal
The following pages link to The Use of Frailty Hazard Models for Unrecognized Heterogeneity That Interacts with Treatment: Considerations of Efficiency and Power (Q3078933):
Displaying 7 items.
- Effects of unmeasured heterogeneity in the linear transformation model for censored data (Q849905) (← links)
- A Design For Survival Studies: A Multi-regional Trial With Unrecognized Heterogeneity (Q2859283) (← links)
- A Statistical Issue About a Phase III Multi-regional Trial for the Survival Data under Accelerated Failure Time Model with Unrecognized Heterogeneity (Q3462389) (← links)
- An Approach to Determine Sample Size and to Allocate Sample Size for a Specific Region in a Multiregional Trial for Survival (Time-to-Event) Data under Accelerated Failure Time Model (Q5177593) (← links)
- Sample Size Determination and Rational Partition for A Multi- Regional Trial for Survival (Time-To-Event) Data with Unrecognized Heterogeneity that Interacts with Treatment (Q5249204) (← links)
- The issue about sample size for survival analysis considering the interaction of unrecognized heterogeneity and treatment (Q5867748) (← links)
- An issue about the efficacy for the time-to-event outcome based on accelerated failure time model with interaction of unrecognized heterogeneity and main effect (Q5875253) (← links)
